Replimune (REPL) Share-based Compensation (2017 - 2025)

Replimune's (REPL) quarterly Share-based Compensation came in at $7.0 million in Q4 2025, down 18.43% year-on-year from $8.6 million in Q4 2024, and down 15.48% quarter-over-quarter from $8.3 million in Q3 2025.

Replimune (REPL) Share-based Compensation (2017 - 2025) Analysis & Trends

Replimune has disclosed Share-based Compensation across 9 years of filings, most recently posting $7.0 million for Q4 2025.

  • Share-based Compensation for Q4 2025 came in at $7.0 million, down 18.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $32.4 million (down 6.52% YoY), and the FY2025 annual result was $35.0 million, up 2.69% from the prior year.
  • Share-based Compensation came in at $7.0 million for Q4 2025 at Replimune, down from $8.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $9.5 million in Q2 2024 to a low of $3.5 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $7.6 million (2022), against an average of $7.5 million.
  • Across the five-year window, Share-based Compensation surged 153.24% in 2021 and dropped 18.43% in 2025, its largest moves.
  • Replimune's Share-based Compensation stood at $5.9 million in 2021, then grew by 18.67% to $7.0 million in 2022, then increased by 17.33% to $8.2 million in 2023, then advanced by 4.84% to $8.6 million in 2024, then decreased by 18.43% to $7.0 million in 2025.
  • The last three Share-based Compensation figures came in at $7.0 million (Q4 2025), $8.3 million (Q3 2025), and $8.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 305,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.71 Bn 91.71 Bn - 26.47 Mn
10 Replimune 780.01 Mn 510.88 Mn - 7.05 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.05 Mn
Dec 31, 2025 7.05 Mn
Sep 30, 2025 8.34 Mn
Sep 30, 2025 8.34 Mn
Jun 30, 2025 8.76 Mn
Jun 30, 2025 8.76 Mn
Mar 31, 2025 8.28 Mn
Mar 31, 2025 8.28 Mn
Dec 31, 2024 8.64 Mn
Dec 31, 2024 8.64 Mn
Sep 30, 2024 8.65 Mn
Sep 30, 2024 8.65 Mn
Jun 30, 2024 9.48 Mn
Jun 30, 2024 9.48 Mn
Mar 31, 2024 7.92 Mn
Mar 31, 2024 7.92 Mn
Dec 31, 2023 8.24 Mn
Dec 31, 2023 8.24 Mn
Sep 30, 2023 9.12 Mn
Sep 30, 2023 9.12 Mn